An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted that after their first 0.25 mg injection of semaglutide they suddenly found vaping disgusting — they gagged and almost vomited when they tried to inhale. They said nausea and a mild headache were the main side effects, and they needed anti-nausea medicine their doctor gave. The surprising part was an immediate, strong aversion to smoking or vaping that they hadn’t expected. Semaglutide is the active drug in popular medications like Ozempic and Wegovy. In plain terms, it’s a lab-made version of a natural hormone that helps control appetite and digestion. It tells parts of your body and brain that you’re less hungry and slows how fast your stomach empties, which can reduce food intake and lead to weight loss. Doctors give it by injection, usually starting at a low dose and increasing over weeks to reduce side effects. This post is an anecdote — a single person’s experience — not a study. Anecdotes can point to something real, but they don’t prove it. Clinical trials and larger reports of semaglutide have documented nausea, vomiting, and altered taste or appetite for certain foods in some people. Some people report changes in how things smell or taste while on these drugs, and that could make tobacco or vape flavors unpleasant. But there’s no strong, published evidence yet that semaglutide reliably causes people to stop liking smoking or vaping across the board. Why this might matter: if semaglutide or similar drugs change smell or taste, they could, in some people, reduce the appeal of smoking or vaping. That’s potentially interesting because most tobacco users find quitting very hard. But right now this is a curiosity rather than a proven quit tool. People who already take semaglutide for weight loss or diabetes might notice unexpected changes in cravings or aversions, and nicotine users might find those changes helpful — or just annoying if they weren’t trying to quit. Caveats and risks are important. This single report doesn’t tell us how common the reaction is, whether it lasts, or whether it would help long-term smoking cessation. Semaglutide commonly causes nausea, vomiting, diarrhea, or constipation, and less common but serious risks include pancreatitis and gallbladder problems. It’s a prescription medicine and should only be used under a doctor’s guidance for approved reasons (like type 2 diabetes or licensed weight-loss use). If someone hopes to quit smoking, proven methods include behavioral support, nicotine replacement, and prescription stop-smoking medicines; anyone thinking of using a drug off-label to quit should discuss it with their clinician. Bottom line: one person felt immediate, strong disgust for vaping after their first semaglutide shot — interesting, but far from proof that the drug stops smoking.
Source: r/Semaglutide